These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 7545228

  • 1. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma--a report from the German Cooperative Pediatric Liver Tumor Study HB-89.
    von Schweinitz D, Hecker H, Harms D, Bode U, Weinel P, Bürger D, Erttmann R, Mildenberger H.
    J Pediatr Surg; 1995 Jun; 30(6):845-52. PubMed ID: 7545228
    [Abstract] [Full Text] [Related]

  • 2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Jun; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 3. [Results of the HB-89 Study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol].
    von Schweinitz D, Bürger D, Bode U, Weinel P, Erttmann R, Hecker H, Mildenberger H.
    Klin Padiatr; 1994 Jun; 206(4):282-8. PubMed ID: 7526028
    [Abstract] [Full Text] [Related]

  • 4. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M, Sher D, Grant D, Deluca E, Alonso E, Whitington PF, Superina RA.
    J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
    Fuchs J, Bode U, von Schweinitz D, Weinel P, Erttmann R, Harms D, Mildenberger H.
    Klin Padiatr; 1999 Nov; 211(4):305-9. PubMed ID: 10472567
    [Abstract] [Full Text] [Related]

  • 7. [Surgical therapy of hepatoblastoma in childhood].
    von Schweinitz D, Hecker H, Bürger D, Mildenberger H.
    Langenbecks Arch Chir; 1995 Nov; 380(6):315-20. PubMed ID: 8558999
    [Abstract] [Full Text] [Related]

  • 8. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology.
    von Schweinitz D, Byrd DJ, Hecker H, Weinel P, Bode U, Bürger D, Erttmann R, Harms D, Mildenberger H.
    Eur J Cancer; 1997 Jul; 33(8):1243-9. PubMed ID: 9301450
    [Abstract] [Full Text] [Related]

  • 9. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor.
    Sasaki F, Matsunaga T, Iwafuchi M, Hayashi Y, Ohkawa H, Ohira M, Okamatsu T, Sugito T, Tsuchida Y, Toyosaka A, Nagahara N, Nishihira H, Hata Y, Uchino J, Misugi K, Ohnuma N, (Japanese Study Group for Pediatric Liver Tumor).
    J Pediatr Surg; 2002 Jun; 37(6):851-6. PubMed ID: 12037748
    [Abstract] [Full Text] [Related]

  • 10. Surgical treatment strategy for advanced hepatoblastoma: Resection versus transplantation.
    Uchida H, Sakamoto S, Sasaki K, Takeda M, Hirata Y, Fukuda A, Hishiki T, Irie R, Nakazawa A, Miyazaki O, Nosaka S, Kasahara M.
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27383. PubMed ID: 30084209
    [Abstract] [Full Text] [Related]

  • 11. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.
    Suita S, Tajiri T, Takamatsu H, Mizote H, Nagasaki A, Inomata Y, Hara T, Okamura J, Miyazaki S, Kawakami K, Eguchi H, Tsuneyoshi M, Committee for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan.
    J Pediatr Surg; 2004 Feb; 39(2):195-8; discussion 195-8. PubMed ID: 14966739
    [Abstract] [Full Text] [Related]

  • 12. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
    Liu APY, Ip JJK, Leung AWK, Luk CW, Li CH, Ho KKH, Lo R, Chan EKW, Chan ACY, Chung PHY, Chiang AKS.
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
    [Abstract] [Full Text] [Related]

  • 13. Surgical Resection for Hepatoblastoma-Updated Survival Outcomes.
    Sunil BJ, Palaniappan R, Venkitaraman B, Ranganathan R.
    J Gastrointest Cancer; 2018 Dec; 49(4):493-496. PubMed ID: 28963691
    [Abstract] [Full Text] [Related]

  • 14. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma--a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94.
    Fuchs J, Rydzynski J, Hecker H, Mildenberger H, Bürger D, Harms D, V Schweinitz D, German Cooperative Liver Tumour Studies HB 89 and HB 94.
    Eur J Pediatr Surg; 2002 Aug; 12(4):255-61. PubMed ID: 12369004
    [Abstract] [Full Text] [Related]

  • 15. Is laparatomy the first step in treatment of childhood liver tumors?--The experience from the German Cooperative Pediatric Liver Tumor Study HB-89.
    von Schweinitz D, Bürger D, Mildenberger H.
    Eur J Pediatr Surg; 1994 Apr; 4(2):82-6. PubMed ID: 7517696
    [Abstract] [Full Text] [Related]

  • 16. Carboplatin-epirubicin regimen for the treatment of hepatoblastoma.
    Blouin P, Brugières L, Tabone MD, Leverger G, Rubie H, Branchereau S, De Kraker J.
    Pediatr Blood Cancer; 2004 Feb; 42(2):149-54. PubMed ID: 14752879
    [Abstract] [Full Text] [Related]

  • 17. Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors.
    Perilongo G, Brown J, Shafford E, Brock P, De Camargo B, Keeling JW, Vos A, Philips A, Pritchard J, Plaschkes J.
    Cancer; 2000 Oct 15; 89(8):1845-53. PubMed ID: 11042582
    [Abstract] [Full Text] [Related]

  • 18. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma.
    Venkatramani R, Wang L, Malvar J, Dias D, Sposto R, Malogolowkin MH, Mascarenhas L.
    Pediatr Blood Cancer; 2012 Sep 15; 59(3):493-8. PubMed ID: 22190448
    [Abstract] [Full Text] [Related]

  • 19. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group.
    Ortega JA, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Finegold MJ, Haas JE, King DR, Liu-Mares W, Sensel MG, Krailo MD.
    J Clin Oncol; 2000 Jul 15; 18(14):2665-75. PubMed ID: 10894865
    [Abstract] [Full Text] [Related]

  • 20. Hepatoblastoma--evolution of management and outcome and significance of histology of the resected tumor. A 31-year experience with 40 cases.
    Davies JQ, de la Hall PM, Kaschula RO, Sinclair-Smith CC, Hartley P, Rode H, Millar AJ.
    J Pediatr Surg; 2004 Sep 15; 39(9):1321-7. PubMed ID: 15359384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.